Ignite Creation Date:
2024-05-06 @ 11:03 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03423992
Status:
UNKNOWN
Last Update Posted:
2021-06-15
First Post:
2018-01-22
Brief Title:
Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas
Sponsor:
Xuanwu Hospital Beijing
Organization:
Xuanwu Hospital Beijing
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-02
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-01-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-01-22
First Submit QC Date:
February 3 2018
Study First Post Date:
2018-02-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-12
Last Update Post Date:
2021-06-15
Last Update Post Date Type:
ACTUAL